Coyle C, Morgan E, Drummond FJ, Sharp L, Gavin A. Do Men Regret Prostate Biopsy: An observational study. Results from the PiCTure Study Decisional Regret following Prostate Biopsy. Accepted by BMC Urology Dec 2016. DOI: 10.1186/s12894-016-0194-y Implications of Research for Services download
L. Steentjes, S. Siesling, F. J. Drummond, J. G. van Manen PhD, L. Sharp PhD, A. Gavin. Factors associated with current and severe physical side-effects after prostate cancer treatment: What men report, Wiley European Journal of Cancer Care, Accepted: 26 August 2016, DOI: 10.1111/ecc.12589.
Gavin AT, Donnelly D, Donnelly C, Drummond FJ, Morgan E, Gormley GJ, Sharp L. Effect of more intense investigation and treatment of prostate cancer on survivor’s physical symptoms, psychological wellbeing and health related quality of life: a two country observational study. Accepted by BMJ Open 20 October 2016.
Sharp L, O'Leary E, Kinnear H, Gavin A, Drummond FJ. Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study. Psycho-Oncology. 2016 Mar;25(3):282-91. doi: 10.1002/pon.3909. Epub 2015 Aug 6. Implications of Research for Services download
Drummond FJ, Kinnear H, Donnelly C, O'Leary E, O'Brien K, Burns RM, Gavin A, Sharp L. Establishing a population-based patient-reported outcomes study (PROMs) using national cancer registries across two jurisdictions; The Prostate Cancer Treatment, your experience (PiCTure) Study. BMJ Open. 2015 Apr 17;5(4). doi: 10.1136/bmjopen-2014-006851
Drummond FJ, O'Leary E, Gavin A; Kinnear H, Sharp L. Mode of prostate cancer detection is associated with the psychological wellbeing of survivors. Results from the PiCTure study. Support Care Cancer. 2016 May;24(5):2297-307. doi: 10.1007/s00520-015-3033-x. Epub 2015 Nov 23. Implications of Research for Services download
Rivas C, Matheson L, Nayoan J, Glaser A, Gavin A, Wright P, Wagland R, Watson E. Ethnicity and the prostate cancer experience: a qualitative metasynthesis. Psychooncology. 2016 Oct;25(10):1147-1156. doi: 10.1002/pon.4222. Epub 2016 Aug 23. Implications of Research for Services download
Gnanapragasam VJ, Lophatananon A, Wright KA, Muir KR, Gavin A, Greenberg DC. Improving clinical risk stratification at diagnosis in primary prostate cancer: a prognostic modelling study. PLoS Med. 2016 Aug 2;13(8):e1002063. doi: 10.1371/journal.pmed.1002063. eCollection 2016. Implications of Research for Services download
Gavin A, Drummond FJ, Donnelly C, O'Leary E, Sharp L, Kinnear HR. Patient reported “ever had” and “current” long term physical symptoms following prostate cancer treatments. BJU International 2015, Jan. http://onlinelibrary.wiley.com/doi/10.1111.Epub 2015 Jun 22. (was the featured article of the month and attracted the editorial) It also has an accompanying short video summarising the study available here
O'Leary E, Drummond FJ, Gavin A, Kinnear H and Sharp L. Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality-of-life in prostate cancer survivors: a curate's egg. Qual Life Res. 2015 Sep;24(9):2219-30. doi: 10.1007/s11136-015-0958-y. Epub 2015 Mar 20.
Drummond FJ, Kinnear H, O’Leary E, Donnelly C, Gavin A, Sharp L. Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study. J Cancer Surviv. 2015 Jun;9(2):361-72. doi: 10.1007/s11764-014-0419-6. Epub 2015 Jan 7.
Connolly D, Van Leeuwen PJ, Bailie J, Black A, Murray LJ, Keane PF, Gavin A. Daily, monthly and seasonal variation in prostate specific antigen levels and the association with weather parameters. Prostate Cancer and Prostatic Diseases, March 2011, doi:10.1038/pcan.2010.37.
van Leeuwen PJ, Connolly D, Tammela TLJ, Auvinen A, Kranse R, Roobol MJ, Schröder FH, Gavin AT. Balancing the harms and benefits of early detection of prostate cancer. Cancer, October 2010, doi: 10.1002/cncr.25474.
Van Leeuwen PJ, Connolly D, Gavin A, Roobol MJ, Black A, Bangma CH, Schroder FH. Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit. European Journal of Cancer, January 2010, doi:10.1016/j.ejca.2009.09.008.
Connolly D, Black A, Murray LJ, Nambirajan T, Keane PF, Gavin A. Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA? Prostate Cancer and Prostatic Diseases, March 2009, doi:10.1038/pcan.2008.37.
Connolly D, Black A, Murray L, Nambirajan T, Keane PF, Gavin AT. The utility of prostate – specific antigen velocity thresholds in clinical practice: a population – based analysis. British Journal of Urology International, June 2008, doi: 10.1111/j.1464-410X.2008.07470.x.
Connolly D, Black A, Gavin AT, Keane PF, Murray L. Baseline prostate-specific-antigen level and risk of prostate cancer and prostate-specific mortality: diagnosis is dependent on the intensity of investigation. Cancer Epidemiology Biomarkers and Prevention, February 2008, doi: 10.1158/1055-9965.EPI-07-0515.
Connolly D, Black A, Murray L, Napolitano G, Gavin AT, Keane PF. Methods of calculating prostate-specific antigen velocity. European Urology, October 2007, doi: 10.1016/j.eururo.2006.12.017.
Carsin AE, Drummond FJ, Black A, van Leeuwen PJ, Sharp L, Murray LJ, Connolly D, Egevad L, Boniol M, Autier P, Comber H, Gavin AT. Impact of PSA testing and prostatic biopsy on cancer incidence and mortality: comparative study between the Republic of Ireland and Northern-Ireland. Cancer Causes and Control, September 2010, doi: 10.1007/s10552-010-9581-y.
Gormley GJ, Catney D, McCall JR, Reilly PM, Gavin AT. Prostate-specific antigen testing: uncovering primary care influences. British Journal Urology International, November 2006, doi: 10.1111/j.1464-410X.2006.06481.x.
Gavin AT, McCarron P, Middleton RJ, Savage G, Catney D, O'Reilly D, Keane PF, Murray LJ. Evidence of prostate cancer screening in a UK region. British Journal of Urology International, online March 2004, DOI: 10.1111/j.1464-410X.2003.04716.x